Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Tuberculosis

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Gastrointestinal infections in the immunocompromised patient].

Acta endoscopica·2020

Same author

The impact of immune response on endochondral bone regeneration.

NPJ Regenerative medicine·2018

Same author

[HIV infection : Reaching a zero risk of transmission].

Revue medicale de Bruxelles·2017

Same author

Isolation unit for multidrug-resistant tuberculosis patients in a low endemic country, a step towards the World Health Organization End TB Strategy.

Epidemiology and infection·2017

Same author

Report of three imported cases of neurocysticercosis in Guadeloupe.

BMC infectious diseases·2017

Same author

Implementation of latent tuberculosis screening in HIV care centres: evaluation in a low tuberculosis incidence setting.

Epidemiology and infection·2015

Same journal

[Breast cancer screening : a tool for informed decision making].

Revue medicale de Bruxelles·2018

Same journal

[Breast cancer screening : present situation and prospects].

Revue medicale de Bruxelles·2018

Same journal

[Guidelines in medical imaging : objectives, limits and radiation protection].

Revue medicale de Bruxelles·2018

Same journal

[How to avoid overmedicalization of the elderly patient ?]

Revue medicale de Bruxelles·2018

Same journal

[Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention].

Revue medicale de Bruxelles·2018

Same journal

[New strategies in specific care for benign prostatic hypertrophy in older men].

Revue medicale de Bruxelles·2018

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

[Pulmonary tuberculosis].

J P Van Vooren¹, K Schepers, M Wanlin

¹Clinique d'Immunodéficiences, Hôpital Erasme, Bruxelles. jean.paul.van.vooren@erasme.ulb.ac.be

Revue Medicale De Bruxelles

|November 25, 2010

Summary

This summary is machine-generated.

Tuberculosis incidence is declining in Belgium, but multidrug-resistant TB remains a concern, particularly in non-native populations. Early diagnosis and appropriate treatment are crucial for managing this global health issue.

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of ¹⁸FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Related Experiment Videos

Last Updated: Jun 6, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of ¹⁸FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Area of Science:

Public Health
Infectious Diseases
Microbiology

Context:

Tuberculosis (TB) presents a significant global health challenge, exacerbated by factors like poverty and HIV.
Multidrug resistance (MDR), defined as resistance to isoniazid and rifampin, is a growing concern in Europe, with origins often traced to the former U.S.S.R.
While overall TB incidence is decreasing in Belgium, localized outbreaks and higher rates among recent immigrants from high-prevalence regions persist.

Purpose:

To analyze the current epidemiological trends of tuberculosis in Belgium.
To highlight the prevalence and characteristics of multidrug-resistant (MDR) TB cases.
To emphasize diagnostic and treatment strategies for TB and MDR-TB.

Summary:

Belgium reported a declining TB incidence of 9.4/100,000 in 2008, with 2.8% of cases exhibiting multidrug resistance (MDR).
MDR-TB cases are disproportionately found in individuals recently arrived from high-prevalence countries, indicating a need for targeted screening and management.
Diagnosis relies on microbiological confirmation, and treatment involves a standard 4-drug regimen, with 5 drugs used for suspected MDR-TB, adjusted based on susceptibility testing.

Impact:

The findings underscore the importance of continued surveillance and tailored interventions for TB control in Belgium.
Understanding the specific challenges of MDR-TB is critical for optimizing treatment protocols and preventing further spread.
Physician awareness of second-line drug toxicities and patient compliance are essential for successful TB treatment outcomes.